GAUCHERS-DISEASE VARIANT CHARACTERIZED BY PROGRESSIVE CALCIFICATION OF HEART-VALVES AND UNIQUE GENOTYPE

被引:158
作者
ABRAHAMOV, A
ELSTEIN, D
GROSSTSUR, V
FARBER, B
GLASER, Y
HADASHALPERN, I
RONEN, S
TAFAKJDI, M
HOROWITZ, M
ZIMRAN, A
机构
[1] SHAARE ZEDEK MED CTR,GAUCHER CLIN,IL-91031 JERUSALEM,ISRAEL
[2] SHAARE ZEDEK MED CTR,DEPT PEDIAT,IL-91031 JERUSALEM,ISRAEL
[3] SHAARE ZEDEK MED CTR,DEPT PEDIAT CARDIOL,IL-91031 JERUSALEM,ISRAEL
[4] SHAARE ZEDEK MED CTR,DEPT PEDIAT NEUROL,IL-91031 JERUSALEM,ISRAEL
[5] SHAARE ZEDEK MED CTR,DEPT OPHTHALMOL,IL-91031 JERUSALEM,ISRAEL
[6] SHAARE ZEDEK MED CTR,DEPT MED,IL-91031 JERUSALEM,ISRAEL
[7] TEL AVIV UNIV,FAC LIFE SCI,DEPT CELLULAR BIOL & IMMUNOL,RAMAT AVIV,ISRAEL
[8] JENIN HLTH DIST OFF,JENIN,JORDAN
来源
LANCET | 1995年 / 346卷 / 8981期
关键词
D O I
10.1016/S0140-6736(95)91688-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gaucher's disease is the most prevalent sphingolipid storage disease, characterised by substantial genetic and phenotypic variability. Cardiac manifestations are rare. We report 12 Arab Gaucher's disease patients, 2-20 years of age, who presented with oculomotor apraxia but only slight classic signs of the disease. All but the youngest had calcifications of the aortic or mitral valves or both. All these patients were homozygous for the rare point mutation D409H (1342C). Valvular calcifications increased with age and showed progression during 2 years of follow-up. Two of the oldest patients underwent aortic valve replacement, and one sibling had died suddenly at age 16, before this study. Corneal opacities were another common feature. The potentially fatal course of this Gaucher's disease variant, and the availability of a reliable PCR-based method for heterozygote detection, mean that population screening and genetic counselling in the geographic area at risk are important. Affected individuals should be closely monitored by echocardiography to gauge the need for valve replacement. The potential of enzyme replacement to prevent these cardiac complications cannot be ascertained at present, because of the high cost of therapy.
引用
收藏
页码:1000 / 1003
页数:4
相关论文
共 19 条
[1]   REPLACEMENT THERAPY FOR INHERITED ENZYME DEFICIENCY - MACROPHAGE-TARGETED GLUCOCEREBROSIDASE FOR GAUCHERS-DISEASE [J].
BARTON, NW ;
BRADY, RO ;
DAMBROSIA, JM ;
DIBISCEGLIE, AM ;
DOPPELT, SH ;
HILL, SC ;
MANKIN, HJ ;
MURRAY, GJ ;
PARKER, RI ;
ARGOFF, CE ;
GREWAL, RP ;
YU, KT .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) :1464-1470
[2]   CONSTRICTIVE PERICARDITIS IN GAUCHERS DISEASE [J].
BENBASSA.J ;
BASSAN, H ;
MILWIDSK.H ;
SACKS, M ;
GROEN, JJ .
AMERICAN JOURNAL OF MEDICINE, 1968, 44 (04) :647-&
[3]  
Beutler E., 1995, METABOLIC MOL BASES, P2641
[4]  
BRADY RO, 1994, 4TH INT GAUCH DIS C
[5]   CALCIFICATION OF THE ASCENDING AORTA AND AORTIC AND MITRAL-VALVES IN GAUCHERS-DISEASE [J].
CASTA, A ;
HAYDEN, K ;
WOLF, WJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (10) :1390-1391
[6]   UNUSUAL EXPRESSION OF GAUCHERS-DISEASE - CARDIOVASCULAR CALCIFICATIONS IN 3 SIBS HOMOZYGOUS FOR THE D409H MUTATION [J].
CHABAS, A ;
CORMAND, B ;
GRINBERG, D ;
BURGUERA, JM ;
BALCELLS, S ;
MERINO, JL ;
MATE, I ;
SOBRINO, JA ;
GONZALEZDUARTE, R ;
VILAGELIU, L .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (09) :740-742
[7]   CARDIAC INVOLVEMENT BY GAUCHERS-DISEASE DOCUMENTED BY RIGHT VENTRICULAR ENDOMYOCARDIAL BIOPSY [J].
EDWARDS, WD ;
HURDEY, HP ;
PARTIN, JR .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (05) :654-654
[8]   OCULOMOTOR APRAXIA - THE PRESENTING SIGN OF GAUCHER DISEASE [J].
GROSSTSUR, V ;
HAREVEN, Y ;
GUTMAN, I ;
AMIR, N .
PEDIATRIC NEUROLOGY, 1989, 5 (02) :128-129
[9]  
HOROWITZ M, 1993, AM J HUM GENET, V53, P921
[10]  
Lee R. E., 1982, GaAs IC Symposium. IEEE Gallium Arsenide Integrated Circuit Symposium. Technical Digest 1982, P177